The anti-CD40 auto-antibody: a biomarker or a factor for the permeability of recurrent focal segmental glomerulosclerosis?
作者信息
Beaudreuil Séverine, Lorenzo Hans Kristian, Durrbach Antoine
机构信息
1 Department of Nephrology, IFRNT, Bicêtre Hospital, University of Paris-XI, Le Kremlin-Bicêtre, France ; 2 INSERM U1197, Av. Paul Vaillant Couturier, 94807 Villejuif, France.
出版信息
Ann Transl Med. 2015 Jun;3(9):115. doi: 10.3978/j.issn.2305-5839.2015.04.06.
Abstract
摘要
相似文献
1
The anti-CD40 auto-antibody: a biomarker or a factor for the permeability of recurrent focal segmental glomerulosclerosis?抗CD40自身抗体：复发性局灶节段性肾小球硬化症通透性的生物标志物还是影响因素？
Ann Transl Med. 2015 Jun;3(9):115. doi: 10.3978/j.issn.2305-5839.2015.04.06.
2
A circulating permeability factor in focal segmental glomerulosclerosis: the hunt continues.局灶节段性肾小球硬化中的一种循环通透性因子：探寻仍在继续。
Clin Kidney J. 2015 Dec;8(6):708-15. doi: 10.1093/ckj/sfv090. Epub 2015 Sep 15.
3
Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis.复发性局灶节段性肾小球硬化症中与肾小球对白蛋白通透性增加相关的循环因子。
N Engl J Med. 1996 Apr 4;334(14):878-83. doi: 10.1056/NEJM199604043341402.
4
Circulating Permeability Factors in Primary Focal Segmental Glomerulosclerosis: A Review of Proposed Candidates.原发性局灶节段性肾小球硬化中的循环通透性因子：对候选因子的综述
Biomed Res Int. 2016;2016:3765608. doi: 10.1155/2016/3765608. Epub 2016 Apr 21.
5
The elusive podocyte crossmatch for recurrent focal segmental glomerulosclerosis. elusive podocyte crossmatch for recurrent focal segmental glomerulosclerosis
Kidney Int. 2019 Mar;95(3):498-500. doi: 10.1016/j.kint.2018.11.032.
6
The Symptoms and Impact of Recurrent Focal Segmental Glomerulosclerosis in Kidney Transplant Recipients: A Conceptual Model of the Patient Experience.移植肾局灶节段肾小球硬化复发患者的症状和影响：患者体验的概念模型。
Adv Ther. 2019 Dec;36(12):3390-3408. doi: 10.1007/s12325-019-01110-5. Epub 2019 Oct 14.
7
Recurrent Focal Segmental Glomerulosclerosis and Abatacept: Case Report.复发性局灶节段性肾小球硬化症与阿巴西普：病例报告
Exp Clin Transplant. 2016 Aug;14(4):456-9. doi: 10.6002/ect.2014.0154. Epub 2014 Nov 27.
8
Galactose therapy reduces proteinuria in patients with recurrent focal segmental glomerulosclerosis after kidney transplantation.半乳糖疗法可降低肾移植后复发性局灶节段性肾小球硬化患者的蛋白尿。
Nephrology (Carlton). 2015 Mar;20 Suppl 1:13-6. doi: 10.1111/nep.12422.
9
A case of recurrent focal segmental glomerulosclerosis after kidney transplantation associated with variant conversion in the Columbia classification.1例肾移植后复发性局灶节段性肾小球硬化症伴哥伦比亚分类中的变异转换
Nephrology (Carlton). 2015 Jul;20 Suppl 2:96-100. doi: 10.1111/nep.12457.
10
Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS.可溶性CD40配体可直接改变肾小球通透性，并可能在局灶节段性肾小球硬化中作为一种循环通透性因子发挥作用。
PLoS One. 2017 Nov 20;12(11):e0188045. doi: 10.1371/journal.pone.0188045. eCollection 2017.
引用本文的文献
1
Increased levels of antibodies to synaptopodin and annexin 1 in patients with primary podocytopathies.原发性足细胞病患者中突触素和膜联蛋白1抗体水平升高。
Front Nephrol. 2024 Oct 31;4:1471078. doi: 10.3389/fneph.2024.1471078. eCollection 2024.
2
Further Evidence That the Soluble Urokinase Plasminogen Activator Receptor Does Not Directly Injure Mice or Human Podocytes.可溶性尿激酶型纤溶酶原激活物受体并不会直接损伤小鼠或人足细胞：进一步的证据
Transplantation. 2020 Jan;104(1):54-60. doi: 10.1097/TP.0000000000002930.
3
Immunology of idiopathic nephrotic syndrome.特发性肾病综合征的免疫学。
Pediatr Nephrol. 2018 Apr;33(4):573-584. doi: 10.1007/s00467-017-3677-5. Epub 2017 Apr 27.
本文引用的文献
1
A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation.一种用于肾移植后FSGS复发移植前预测的循环抗体检测组。
Sci Transl Med. 2014 Oct 1;6(256):256ra136. doi: 10.1126/scitranslmed.3008538.
2
Successful treatment of recurrent focal segmental glomerulosclerosis with a low dose rituximab in a kidney transplant recipient.肾移植受者低剂量利妥昔单抗治疗复发性局灶节段性肾小球硬化症的疗效。
Ren Fail. 2014 May;36(4):623-6. doi: 10.3109/0886022X.2014.882238. Epub 2014 Feb 6.
3
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.循环尿激酶受体是局灶节段性肾小球硬化的病因。
Nat Med. 2011 Jul 31;17(8):952-60. doi: 10.1038/nm.2411.
4
Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population.循环可溶性尿激酶型纤溶酶原激活物受体可预测普通人群中的癌症、心血管疾病、糖尿病和死亡率。
J Intern Med. 2010 Sep;268(3):296-308. doi: 10.1111/j.1365-2796.2010.02252.x. Epub 2010 May 28.
5
Antibodies to protein tyrosine phosphatase receptor type O (PTPro) increase glomerular albumin permeability (P(alb)).针对O型蛋白酪氨酸磷酸酶受体（PTPro）的抗体可增加肾小球白蛋白通透性（P(alb)）。
Am J Physiol Renal Physiol. 2009 Jul;297(1):F138-44. doi: 10.1152/ajprenal.00122.2008. Epub 2009 Apr 29.
6
The focal segmental glomerulosclerosis permeability factor: biochemical characteristics and biological effects.局灶节段性肾小球硬化通透性因子：生化特性及生物学效应
Exp Biol Med (Maywood). 2004 Jan;229(1):85-98. doi: 10.1177/153537020422900111.
7
Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis.复发性局灶节段性肾小球硬化症中与肾小球对白蛋白通透性增加相关的循环因子。
N Engl J Med. 1996 Apr 4;334(14):878-83. doi: 10.1056/NEJM199604043341402.
8
Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome.血浆蛋白吸附对复发性肾病综合征肾移植受者蛋白质排泄的影响。
N Engl J Med. 1994 Jan 6;330(1):7-14. doi: 10.1056/NEJM199401063300102.
Zotero 插件